hydrazine has been researched along with Respiratory Syncytial Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pickens, JA; Tripp, RA | 1 |
| Ghildyal, R; Jorquera, PA; Luczo, JM; Mathew, C; Pickens, J; Tamir, S; Tripp, RA; Williams, C | 1 |
1 review(s) available for hydrazine and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.
Topics: Acrylamides; Animals; Antiviral Agents; Apoptosis; Cell Line, Tumor; Clinical Trials as Topic; Drug Discovery; Exportin 1 Protein; Humans; Hydrazines; Immunologic Factors; Influenza, Human; Karyopherins; Orthomyxoviridae; Receptors, Cytoplasmic and Nuclear; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human | 2018 |
1 other study(ies) available for hydrazine and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
Topics: A549 Cells; Acrylamides; Active Transport, Cell Nucleus; Animals; Antiviral Agents; Apoptosis; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; Exportin 1 Protein; Glycoproteins; Humans; Hydrazines; Karyopherins; Receptors, Cytoplasmic and Nuclear; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Syncytial Viruses; Vero Cells; Virus Replication | 2019 |